Single skull metastasis 15 years after primary treatment of prostate cancer and with undetectable PSA levels: A case report and review of the literature

Marco Messina, Francesco Ricci, Bruno Spina, Francesco Boccardo

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Prostate cancer is the first cause of skull metastases in men, accounting for 12-18% of all cases. This condition is generally a late event in the course of the disease, involving patients with disseminated lesions. Quite rarely is skull involvement the first and single site of distant recurrence. We report the case of a patient who developed a single skull lesion 15 years after primary treatment of prostate cancer, in the presence of undetectable PSA levels. Pathological assessment performed after resection of the lesion revealed a metastasis from prostate carcinoma. Basing on this experience the appearance of craniofacial pain or a nerve deficit in patients with a history of prostate cancer should alert the clinician to exclude distant recurrence of disease, even in the presence of undetectable PSA levels and even if many years have elapsed since the treatment of the primary tumor. Knowledge of these manifestations will reduce any diagnostic delay and lead to the effective delivery of appropriate treatment.

Original languageEnglish
JournalTumori
Volume99
Issue number5
DOIs
Publication statusPublished - Sep 2013

Fingerprint

Skull
Prostatic Neoplasms
Neoplasm Metastasis
Recurrence
Facial Pain
Prostate
Therapeutics
Carcinoma
Neoplasms

Keywords

  • Prostate cancer
  • Skull metastasis
  • Undetectable PSA levels

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

@article{c5b9a4dd1401471a8a3433f5d316e5d9,
title = "Single skull metastasis 15 years after primary treatment of prostate cancer and with undetectable PSA levels: A case report and review of the literature",
abstract = "Prostate cancer is the first cause of skull metastases in men, accounting for 12-18{\%} of all cases. This condition is generally a late event in the course of the disease, involving patients with disseminated lesions. Quite rarely is skull involvement the first and single site of distant recurrence. We report the case of a patient who developed a single skull lesion 15 years after primary treatment of prostate cancer, in the presence of undetectable PSA levels. Pathological assessment performed after resection of the lesion revealed a metastasis from prostate carcinoma. Basing on this experience the appearance of craniofacial pain or a nerve deficit in patients with a history of prostate cancer should alert the clinician to exclude distant recurrence of disease, even in the presence of undetectable PSA levels and even if many years have elapsed since the treatment of the primary tumor. Knowledge of these manifestations will reduce any diagnostic delay and lead to the effective delivery of appropriate treatment.",
keywords = "Prostate cancer, Skull metastasis, Undetectable PSA levels",
author = "Marco Messina and Francesco Ricci and Bruno Spina and Francesco Boccardo",
year = "2013",
month = "9",
doi = "10.1700/1377.15319",
language = "English",
volume = "99",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "5",

}

TY - JOUR

T1 - Single skull metastasis 15 years after primary treatment of prostate cancer and with undetectable PSA levels

T2 - A case report and review of the literature

AU - Messina, Marco

AU - Ricci, Francesco

AU - Spina, Bruno

AU - Boccardo, Francesco

PY - 2013/9

Y1 - 2013/9

N2 - Prostate cancer is the first cause of skull metastases in men, accounting for 12-18% of all cases. This condition is generally a late event in the course of the disease, involving patients with disseminated lesions. Quite rarely is skull involvement the first and single site of distant recurrence. We report the case of a patient who developed a single skull lesion 15 years after primary treatment of prostate cancer, in the presence of undetectable PSA levels. Pathological assessment performed after resection of the lesion revealed a metastasis from prostate carcinoma. Basing on this experience the appearance of craniofacial pain or a nerve deficit in patients with a history of prostate cancer should alert the clinician to exclude distant recurrence of disease, even in the presence of undetectable PSA levels and even if many years have elapsed since the treatment of the primary tumor. Knowledge of these manifestations will reduce any diagnostic delay and lead to the effective delivery of appropriate treatment.

AB - Prostate cancer is the first cause of skull metastases in men, accounting for 12-18% of all cases. This condition is generally a late event in the course of the disease, involving patients with disseminated lesions. Quite rarely is skull involvement the first and single site of distant recurrence. We report the case of a patient who developed a single skull lesion 15 years after primary treatment of prostate cancer, in the presence of undetectable PSA levels. Pathological assessment performed after resection of the lesion revealed a metastasis from prostate carcinoma. Basing on this experience the appearance of craniofacial pain or a nerve deficit in patients with a history of prostate cancer should alert the clinician to exclude distant recurrence of disease, even in the presence of undetectable PSA levels and even if many years have elapsed since the treatment of the primary tumor. Knowledge of these manifestations will reduce any diagnostic delay and lead to the effective delivery of appropriate treatment.

KW - Prostate cancer

KW - Skull metastasis

KW - Undetectable PSA levels

UR - http://www.scopus.com/inward/record.url?scp=84893431311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893431311&partnerID=8YFLogxK

U2 - 10.1700/1377.15319

DO - 10.1700/1377.15319

M3 - Article

AN - SCOPUS:84893431311

VL - 99

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 5

ER -